sequence standard reference (National Institute of Standards and Technology)
92
Structured Review
National Institute of Standards and Technology
sequence standard reference
Sequence Standard Reference, supplied by National Institute of Standards and Technology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+standard+reference/pm37683310-95-33-21
Average 92 stars, based on 1 article reviews
Sequence Standard Reference, supplied by National Institute of Standards and Technology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequence+standard+reference/pm37683310-95-33-21
Average 92 stars, based on 1 article reviews
sequence standard reference - by Bioz Stars,
2026-09
92/100 stars
Images
Related Articles
Targeted Proteomics:Article Title: Comparison of the complete mtDNA genome sequences of human cell lines – HL-60 and GM10742A – from individuals with pro-myelocytic leukemia and leber hereditary optic neuropathy, respectively, and the inclusion of HL-60 in the NIST human mitochondrial DNA standard reference material – SRM 2392-I Article Snippet: Forensic and clinical laboratories benefit from DNA standard reference materials (SRMs) that provide the quality control and assurance that their results from sequencing unknown samples are correct.. Therefore, the mitochondrial DNA (mtDNA) genome of HL-60, a promyelocytic leukemia cell line, has been completely sequenced by four laboratories and will be available to the forensic and medical communities in the spring of 2003; it will be called National Institute of Standards and Technology (NIST) SRM 2392-I.. NIST human mtDNA SRM 2392 will continue to be available and includes the DNA from two apparently healthy individuals. Article Title: Identification of new variants in MTRNR1 and MTRNR2 genes using whole mitochondrial genome sequencing in a Taiwanese family with MERRF (myoclonic epilepsy with ragged-red fibers) syndrome. Article Snippet: Mitochondrial encephalomyopathy is a multi-system disorder mostly caused by inborn errors of the oxidative phosphorylation (OXPHOS) system and usually manifested as complex neurological disorder and muscle weakness.. Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is one of the major subtypes of mitochondrial disease associated with the m.8344A>G mutation in mitochondrial tRNALys gene.. In addition to the symptoms in central nervous and muscle systems, a portion of the patients may develop hearing loss, which has been linked to the genetic mutations of mitochondrial DNA (mtDNA) especially in the mitochondrial ribosome RNA (rRNA) gene. Sequencing:Article Title: Identification of new variants in MTRNR1 and MTRNR2 genes using whole mitochondrial genome sequencing in a Taiwanese family with MERRF (myoclonic epilepsy with ragged-red fibers) syndrome. Article Snippet: Mitochondrial encephalomyopathy is a multi-system disorder mostly caused by inborn errors of the oxidative phosphorylation (OXPHOS) system and usually manifested as complex neurological disorder and muscle weakness.. Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is one of the major subtypes of mitochondrial disease associated with the m.8344A>G mutation in mitochondrial tRNALys gene.. In addition to the symptoms in central nervous and muscle systems, a portion of the patients may develop hearing loss, which has been linked to the genetic mutations of mitochondrial DNA (mtDNA) especially in the mitochondrial ribosome RNA (rRNA) gene. Article Title: Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer. Article Snippet: Background : Lung cancer is the leading cause of cancer deaths worldwide.. Recent years have brought tremendous progress in the development of genomic and proteomic platforms to study lung cancer progression and biomarker identification.. Objective : To evaluate and integrate potential innovations of ‘omics’ (e.g., genomics and proteomics) technologies in dissecting biomarkers for lung cancer. Article Title: Characterization of NIST standard reference materials by next generation sequencing Article Snippet: The National Institute of Standards and Technology (NIST) offers certified Standard Reference Materials (SRMs) for laboratories which perform DNA-based human identity testing.. Developed by the Applied Genetics Group at NIST, forensic DNA SRMs are well characterized for relevant markers such as autosomal and Y-chromosomal short tandem repeats (STRs) and mitochondrial DNA (mtDNA) sequence.. Characterization of the SRMs has been performed by capillary gel electrophoresis fragment-based genotyping analysis and/or Sanger type sequencing. Next-Generation Sequencing:Article Title: Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer. Article Snippet: Background : Lung cancer is the leading cause of cancer deaths worldwide.. Recent years have brought tremendous progress in the development of genomic and proteomic platforms to study lung cancer progression and biomarker identification.. Objective : To evaluate and integrate potential innovations of ‘omics’ (e.g., genomics and proteomics) technologies in dissecting biomarkers for lung cancer. Article Title: Characterization of NIST standard reference materials by next generation sequencing Article Snippet: The National Institute of Standards and Technology (NIST) offers certified Standard Reference Materials (SRMs) for laboratories which perform DNA-based human identity testing.. Developed by the Applied Genetics Group at NIST, forensic DNA SRMs are well characterized for relevant markers such as autosomal and Y-chromosomal short tandem repeats (STRs) and mitochondrial DNA (mtDNA) sequence.. Characterization of the SRMs has been performed by capillary gel electrophoresis fragment-based genotyping analysis and/or Sanger type sequencing. Biomarker Discovery:Article Title: Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer. Article Snippet: Background : Lung cancer is the leading cause of cancer deaths worldwide.. Recent years have brought tremendous progress in the development of genomic and proteomic platforms to study lung cancer progression and biomarker identification.. Objective : To evaluate and integrate potential innovations of ‘omics’ (e.g., genomics and proteomics) technologies in dissecting biomarkers for lung cancer. Construct:Article Title: Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Article Snippet: .. The standard curve for the assessment of the Purification:Article Title: Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Article Snippet: .. The standard curve for the assessment of the |